31 – 40 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
- Contribution to journal › Article
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
- Contribution to journal › Article
- 2022
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
- Contribution to journal › Article
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
- Contribution to journal › Article
-
Mark
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
- Contribution to journal › Article
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
- Contribution to journal › Article
-
Mark
MRI-only radiotherapy of gliomas – a prospective implementation study.
- Contribution to journal › Published meeting abstract
-
Mark
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
- Contribution to journal › Article
-
Mark
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
- Contribution to journal › Article
